SCHEMBL7079468

SCHEMBL7079468

COc1ccccc1C1(CCCN)C2CC3CC(C2)CC1C3

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 1/20 0.37
HTR2C P28335 1/20 0.37
HTR2B P41595 1/20 0.37
CHRM2 P08172 2/20 0.36
CHRM4 P08173 1/20 0.36
CHRM5 P08912 1/20 0.36
CHRM1 P11229 1/20 0.36
CHRM3 P20309 1/20 0.36
SIGMAR1 Q99720 2/20 0.36
P2RX7 Q99572 1/20 0.36
TAAR1 Q96RJ0 1/20 0.36
HSD11B1 P28845 2/20 0.36
EPHX2 P34913 1/20 0.34
BACE1 P56817 1/20 0.34
KCNH2 Q12809 1/20 0.34
KMT2A Q03164 2/20 0.34
MEN1 O00255 1/20 0.34
FAAH O00519 1/20 0.33
CNR2 P34972 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL7191573 0.99 HTR2C (0.39) HTR2AHTR2CHTR2BCHRM2CHRM4
SCHEMBL7080304 0.82 HSD11B1 (0.38) HTR2AHTR2CHTR2BSIGMAR1P2RX7
SCHEMBL7079499 0.81 HSD11B1 (0.39) HSD11B1
Hydrochloric Acid SCHEMBL7079630 0.81 HSD11B1 (0.38) HTR2AHTR2CHTR2BSIGMAR1P2RX7
Hydrochloric Acid SCHEMBL7135312 0.80 HSD11B1 (0.38) HSD11B1
SCHEMBL7079043 0.79 HSD11B1 (0.37) HTR2AHTR2CHTR2BP2RX7TAAR1
SCHEMBL7082807 0.78 HSD11B1 (0.38) HTR2AHTR2CHTR2BSIGMAR1P2RX7
SCHEMBL7082431 0.77 HSD11B1 (0.38) HSD11B1
Hydrochloric Acid SCHEMBL7079481 0.77 HSD11B1 (0.37) HTR2AHTR2CHTR2BSIGMAR1P2RX7
Hydrochloric Acid SCHEMBL7082006 0.76 HSD11B1 (0.38) HSD11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003064372-A1 2-ADAMANTYLALKYLAMINES AND THEIR USE IN THE TREATMENT OF CONDITIONS GENERALLY ASSOCIATED WITH ABNORMALITIES IN GLUTAMATERGIC TRANSMISSION VERNALIS RESEARCH LIMITED (GB) 2003-08-07 WO claimed
WO-2003064372-A1 2-ADAMANTYLALKYLAMINES AND THEIR USE IN THE TREATMENT OF CONDITIONS GENERALLY ASSOCIATED WITH ABNORMALITIES IN GLUTAMATERGIC TRANSMISSION VERNALIS RESEARCH LIMITED (GB) 2003-08-07 WO disclosed